Skip to content

Clinical trials

Phase 1/2 Severe Acute Respiratory Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Severe Acute Respiratory Syndrome Phase: Phase 1/2 Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
202010
20212
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Unknown status2
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Research Institute for Biological Safety Problems2
Apellis Pharmaceuticals, Inc.1
BioNTech SE1
D'Or Institute for Research and Education1
Emory University1
Hunter Holmes Mcguire Veteran Affairs Medical Center1
Maria de los Angeles Peral de Bruno1
Ministry of Public Health, Argentina1
Novavax1
Restem, LLC.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Severe Acute Respiratory Syndrome13
COVID-1911
Coronavirus Infections3
Respiratory Distress Syndrome3
Acute Lung Injury2
Pneumonia2
Hypoxia1
RNA Virus Infections1
Respiratory Tract Infections1
Sepsis1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.